Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam

The treatment of carbapenem-resistant Acinetobacter baumannii/calcoaceticus complex (CRAB) presents significant treatment challenges. We report the case of a 42-year-old woman with CRAB meningitis who experienced persistently positive cerebrospinal fluid (CSF) cultures for 13 days despite treatment...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2024-10, Vol.79 (4), p.819
Hauptverfasser:	Tamma, Pranita D, Immel, Shanan, Karaba, Sara M, Soto, Caitlin L, Conzemius, Rick, Gisriel, Emily, Tekle, Tsigereda, Stambaugh, Haley, Johnson, Emily, Tornheim, Jeffrey A, Simner, Patricia J
Format:	Artikel
Sprache:	eng
Schlagworte:	Acinetobacter baumannii - drug effects Acinetobacter baumannii - genetics Acinetobacter baumannii - isolation & purification Acinetobacter Infections - drug therapy Acinetobacter Infections - microbiology Adult Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Azabicyclo Compounds - therapeutic use Bacterial Proteins - genetics beta-Lactamases - genetics Carbapenems - pharmacology Carbapenems - therapeutic use Cephalosporins - pharmacology Cephalosporins - therapeutic use Drug Combinations Drug Resistance, Multiple, Bacterial - genetics Female Humans Meningitis, Bacterial - drug therapy Meningitis, Bacterial - microbiology Microbial Sensitivity Tests Sulbactam - pharmacology Sulbactam - therapeutic use Treatment Outcome Whole Genome Sequencing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!